Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3130-3142

  Marshansky, V ^a   Wang, X ^a   Bertrand, R ^a   Luo, H ^a   Duguid, W ^a   Chinnadurai, G ^a   Kanaan, N ^a   Vu, M D ^a   Wu, J ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; GENE PRODUCT; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN BIK; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON TRANSPORT; GENE OVEREXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 0035284812     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3130     Document Type: Article

References (53)

1. Selective protein degradation: A journey's end within the proteasome
2. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex: Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids
3. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
4. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway
5. Cdc28-mediated control of Cln3 cyclin degradation
6. G1 cyclin degradation: The PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover
7. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins
8. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
9. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
10. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
11. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
12. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome
13. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
14. Role of proteasomes in T cell activation and proliferation
15. L forms an ion channel in synthetic lipid membranes
16. Establishment of propagatable epithelial cell lines from normal adult rat pancreas
17. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
18. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression
19. Bax-a promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells
20. Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis
21. Molecular cloning of the cDNA of mouse mitochondrial NADP-dependent isocitrate dehydrogenase and the expression of the gene during lymphocyte activation
22. 2 subunit-related gene during lymphocyte activation
23. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins
24. d-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment
25. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess δψ changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis
26. Proteasomes play an essential role in thymocyte apoptosis
27. Proteasome regulation of activation-induced T cell death
28. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
29. Rapamycin inhibits proteasome activator expression and proteasome activity
30. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase
31. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
32. Different cleavage pattern for poly (ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells
33. Bcl-2 family-regulator of cell death
34. Mitochondrial control of apoptosis
35. Apaf-1, a human protein homologous to c-Elegans ced-4, participates in cytochrome c-dependent activation of caspase-3
36. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
37. The Bcl-2 protein family arbiters of cell survival
38. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
39. Regulation of apoptosis by BH3 domains in a cell-free system
40. 2+ homeostasis by Bcl-2
41. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity
42. Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis
43. Expression of the death gene Bik/NBK promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice
44. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells
45. Developmental and aging changes of Bak expression in the human brain
46. Apoptosis during bone-like tissue development in vitro
47. Bcl-2 expression and the development of endometrial carcinoma
48. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic simuli
49. The proteasome controls the protein level Ki-67 in human pancreatic cancer cells
50. Caspase-9, Bcl-X-L, and Apaf-1 form a ternary complex
51. Apoptosis in hematopoietic cells (FL5.12) caused by interleukin-3 withdrawal: Relationship to caspase activity and the loss of glutathione
52. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
53. Suppression of TNF-α-induced apoptosis by NF-κB